Replimune Group Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.19

+0.19 (+1.90%)

As of Jun 21, 10:18 PM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 1 8%

Hold 7 54%

Sell 5 38%

Price Target

Analyst Price Target +248.9% upside

Low Target $27.68

Average Target $35.55

High Target $47.36

Current Price $10.19

Current
$10.19

Target
$35.55

$27.68 $35.55 avg $47.36

Scenario Analysis

Bear Case

$27.68

171.6%

Low target

Base Case

$35.55

+248.9%

Avg target

Bull Case

$47.36

+364.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$13.24

-23.0% from high

52-Week Low

$1.50

+579.3% from low

Target vs 52W High

$35.55

+168.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%